Fujisaki, Tomoaki
Ishikawa, Takayuki
Takamatsu, Hiroyuki
Suzuki, Kenshi
Min, Chang-Ki
Lee, Jae Hoon
Wang, Jianping
Carson, Robin
Crist, Wendy
Qi, Ming
Nagafuji, Koji
Funding for this research was provided by:
Janssen Research & Development, LLC
Article History
Received: 19 August 2019
Accepted: 29 August 2019
First Online: 16 October 2019
Compliance with ethical standards
:
: Hiroyuki Takamatsu received honoraria from Janssen. Kenshi Suzuki received honoraria from Celgene, Takeda, and Janssen and consulted for Takeda. Jianping Wang, Robin Carson, Wendy Crist, and Ming Qi are employees of Janssen. Tomoaki Fujisaki, Takayuki Ishikawa, Chang-Ki Min, Jae Hoon Lee, and Koji Nagafuji have no conflicts of interest to disclose.
: The study protocol and amendments for this investigation were reviewed and approved by affiliated Independent Ethics Committees and Institutional Review Boards. The study was conducted in accordance with ethical principles based on the Declaration of Helsinki and is consistent with Good Clinical Practices and applicable regulatory requirements.
: All patients provided oral and written consent to participate in this study.